Home › Trial NCT01237483
Reirradiation and Erbitux in the HNSCC
- Trial IDNCT01237483
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorGroupe Oncologie Radiotherapie Tete et Cou
- Enrollment50
- Start date2010-10
- ConditionsHead and Neck Cancer Squamous Cell
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.